Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2018-06-21 Declaration of Voting R…
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filing dated June 20, 2018, reporting on the departure of a director and the results of the Annual Meeting of Stockholders, including election of directors and voting outcomes. It contains specific voting results and announcements related to board changes and shareholder votes. The key sections are Item 5.02 (Departure of Directors or Principal Officers) and Item 5.07 (Submission of Matters to a Vote of Security Holders). This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA) because it provides official results from shareholder votes at the Annual Meeting. The document length is 3665 characters, which is short and focused on voting results and board changes, not a full annual report or other detailed financial report. Therefore, the correct classification is DVA with high confidence.
2018-06-21 English
FORM 4
Director's Dealing
2018-06-21 English
FORM 4
Director's Dealing
2018-06-20 English
FORM 4
Director's Dealing
2018-05-11 English
10-Q
Interim / Quarterly Report Q1 2018
2018-05-04 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filing dated May 4, 2018, reporting earnings for the first quarter ended March 31, 2018. It includes a press release as Exhibit 99.1 that reports financial results for the quarter. The document length is 3270 characters, which is relatively short and primarily contains an announcement of earnings results rather than detailed financial statements or comprehensive analysis. The text states that the press release is attached and is the main content reporting the financial results. This fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only. It is not a full interim report (IR) because it lacks substantive financial data and analysis, nor is it an Annual Report or other detailed filing. Therefore, the appropriate classification is Earnings Release (ER).
2018-05-04 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.